UK allocations of funding for coronavirus vaccines to be examined
30 June 2020
The International Development Committee takes evidence from development stakeholders.
- Parliament TV: Impact of the Coronavirus
- Inquiry: Impact of the Coronavirus
- International Development Committee
Witnesses
Thursday 2 July 2020 (virtual)
- Please note there is no physical access to Parliament
- Session will be conducted with remote participation by witnesses and Committee members
At 2.30pm
- Dr Samia Saad, Director of Resource Mobilisation, Coalition for Epidemic Preparedness Innovations (CEPI)
- Dr Josie Golding, Epidemics Lead, Wellcome Trust (part of both CEPI and the Covid Therapeutics Accelerator (CTA) partnership)
- Professor David Heymann CBE, Board member, Foundation for Innovative New Diagnostics (FIND)
Purpose of the Session
On Thursday 2 July, the International Development Committee will be holding an oral evidence session as part of its inquiry Humanitarian crises monitoring: impact of coronavirus, hearing from witnesses who were due to give evidence to the inquiry on 16 June. The panel was postponed due to urgent business in the House of Commons.
This session is focused on the UK allocations of funding for accelerated research, development and production of vaccines, treatments and tests in the battle against the coronavirus pandemic and COVID-19. The panel that was able to be heard as planned on 16 June provided evidence on continuing efforts to tackle other, long-standing, diseases and health challenges.